(Q34409088)

2 August 2017

Progress in the treatment of myasthenia gravis (English)

1 reference

2 August 2017

0 references

1

Ralf Gold

1 reference

2 August 2017

3

Klaus V Toyka

1 reference

2 August 2017

Reinhard Hohlfeld

2

1 reference

PubMed ID

21180568

2 August 2017

language of work or name

1 reference

1 September 2008

1 reference

Therapeutic advances in neurological disorders

2 August 2017

1 reference

2 August 2017

1

1 reference

2 August 2017

2

1 reference

2 August 2017

36-51

1 reference

Intravenous immunoglobulin for myasthenia gravis

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Corticosteroids for myasthenia gravis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Immunotherapy in autoimmune neuromuscular disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Current status of the diagnosis and treatment of thymoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

High-dose intravenous methylprednisolone in myasthenia gravis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Present and future treatment of myasthenia gravis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Effects of myasthenic immunoglobulins and of prednisolone on spontaneous miniature end-plate potentials in mouse diaphragms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Intrathymic pathogenesis and dual genetic control of myasthenia gravis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3002545

Activation and blockade of mouse muscle nicotinic channels by antibodies directed against the binding site of the acetylcholine receptor.

6 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

Myasthenia gravis: reactivation of clinical disease and of autoimmune factors after discontinuation of long-term azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

Mycophenolate mofetil in the therapy of severe myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

Treatment of Myasthenia Gravis Exacerbation With Intravenous Immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285608093888

Azathioprine toxicity during long-term immunosuppression of generalized myasthenia gravis

21 January 2018

1 reference

12 December 2020

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

1 reference

12 December 2020

Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis

1 reference

12 December 2020

Effect of immunosuppressive drugs (azathioprine)

1 reference

12 December 2020

Azathioprine in the treatment of myasthenia gravis

1 reference

12 December 2020

Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity

1 reference

12 December 2020

Treatment of severe myasthenia gravis with protein A immunoadsorption and cyclophosphamide

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1177/1756285608093888

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

PubMed ID

21180568